80 related articles for article (PubMed ID: 20826026)
1. Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapy.
Schmitz AC; van den Bosch MA; Loo CE; Mali WP; Bartelink H; Gertenbach M; Holland R; Peterse JL; Rutgers EJ; Gilhuijs KG
Radiother Oncol; 2010 Nov; 97(2):225-32. PubMed ID: 20826026
[TBL] [Abstract][Full Text] [Related]
2. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation.
Al-Hallaq HA; Mell LK; Bradley JA; Chen LF; Ali AN; Weichselbaum RR; Newstead GM; Chmura SJ
Cancer; 2008 Nov; 113(9):2408-14. PubMed ID: 18823018
[TBL] [Abstract][Full Text] [Related]
4. Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging?
Grimsby GM; Gray R; Dueck A; Carpenter S; Stucky CC; Aspey H; Giurescu ME; Pockaj B
Am J Surg; 2009 Oct; 198(4):500-4. PubMed ID: 19800455
[TBL] [Abstract][Full Text] [Related]
5. True local recurrence rate in the conserved breast after magnetic resonance imaging-targeted radiotherapy.
Whipp E; Beresford M; Sawyer E; Halliwell M
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):984-90. PubMed ID: 19577866
[TBL] [Abstract][Full Text] [Related]
6. Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: potential relevance for MRI-guided localized therapy.
Schmitz AC; Pengel KE; Loo CE; van den Bosch MA; Wesseling J; Gertenbach M; Alderliesten T; Mali WP; Rutgers EJ; Bartelink H; Gilhuijs KG
Radiother Oncol; 2012 Jul; 104(1):11-8. PubMed ID: 22652095
[TBL] [Abstract][Full Text] [Related]
7. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation.
Tendulkar RD; Chellman-Jeffers M; Rybicki LA; Rim A; Kotwal A; Macklis R; Obi BB
Cancer; 2009 Apr; 115(8):1621-30. PubMed ID: 19224552
[TBL] [Abstract][Full Text] [Related]
8. MRI-guided ablation of breast cancer: where do we stand today?
Postma EL; van Hillegersberg R; Daniel BL; Merckel LG; Verkooijen HM; van den Bosch MA
J Magn Reson Imaging; 2011 Aug; 34(2):254-61. PubMed ID: 21780220
[TBL] [Abstract][Full Text] [Related]
9. Freehand MRI-guided preoperative needle localization of breast lesions after MRI-guided vacuum-assisted core needle biopsy without marker placement.
van de Ven SM; Lin MC; Daniel BL; Sareen P; Lipson JA; Pal S; Dirbas FM; Ikeda DM
J Magn Reson Imaging; 2010 Jul; 32(1):101-9. PubMed ID: 20575077
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.
Hwang N; Schiller DE; Crystal P; Maki E; McCready DR
Ann Surg Oncol; 2009 Nov; 16(11):3000-9. PubMed ID: 19603233
[TBL] [Abstract][Full Text] [Related]
11. [MRI-guided biopsy of suspicious abnormalities in the breast].
Meeuwis C; van den Bosch MA; Houwert KA; Fernandez-Gallardo AM; van Hillegersberg R; Mali WP
Ned Tijdschr Geneeskd; 2006 Aug; 150(32):1780-7. PubMed ID: 16948241
[TBL] [Abstract][Full Text] [Related]
12. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy.
De Meerleer G; Villeirs G; Bral S; Paelinck L; De Gersem W; Dekuyper P; De Neve W
Radiother Oncol; 2005 Jun; 75(3):325-33. PubMed ID: 15967524
[TBL] [Abstract][Full Text] [Related]
13. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.
Buchanan CL; Morris EA; Dorn PL; Borgen PI; Van Zee KJ
Ann Surg Oncol; 2005 Dec; 12(12):1045-53. PubMed ID: 16244803
[TBL] [Abstract][Full Text] [Related]
14. Breast magnetic resonance imaging: an essential role in malignant axillary lymphadenopathy of unknown origin.
McMahon K; Medoro L; Kennedy D
Australas Radiol; 2005 Oct; 49(5):382-9. PubMed ID: 16174176
[TBL] [Abstract][Full Text] [Related]
15. Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back?
Kuhl C; Kuhn W; Braun M; Schild H
Breast; 2007 Dec; 16 Suppl 2():S34-44. PubMed ID: 17959382
[TBL] [Abstract][Full Text] [Related]
16. MRI-guided radiofrequency ablation of breast cancer: preliminary clinical experience.
van den Bosch M; Daniel B; Rieke V; Butts-Pauly K; Kermit E; Jeffrey S
J Magn Reson Imaging; 2008 Jan; 27(1):204-8. PubMed ID: 18050333
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
[TBL] [Abstract][Full Text] [Related]
18. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional volumetric analysis of irradiated lung with adjuvant breast irradiation.
Teh AY; Park EJ; Shen L; Chung HT
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1309-15. PubMed ID: 19427749
[TBL] [Abstract][Full Text] [Related]
20. Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?
Grobmyer SR; Mortellaro VE; Marshall J; Higgs GM; Hochwald SN; Mendenhall NP; Copeland EM; Cance WG
J Am Coll Surg; 2008 May; 206(5):1045-50; discussion 1050-2. PubMed ID: 18471753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
